Proteus mirabilis (2018 Data)
Antibiotic |
% Susceptible |
Antibiotic |
% Susceptible |
|
Ampicillin | 81 |
Imipenem | + |
|
Azithromycin | -* |
Levofloxacin | 79 |
|
Aztreonam | 100 |
Meropenem | 100 |
|
Cefazolin | 89 |
Moxifloxacin | +
|
|
Cefepime | 100 |
Nitrofurantoin | 0
|
|
Ceftazidime | 99 |
Oxacillin/Naf | - |
|
Ceftriaxone | 98 |
Penicillin | - |
|
Cefuroxime | 98 |
Piperacillin | +
|
|
Ciprofloxacin | 77 |
Piperacillin/tazo | 100 |
|
Clarithromycin | -* |
Ticarcillin/Clav | + |
|
Clindamycin | -* |
Tobramycin | 90 |
|
Doxycycline | - |
TMP/SMX | 77 |
|
Erythromycin | -* |
Unasyn/Aug | 91 |
|
Gentamicin | 89 |
Vancomycin | -* |
|
Number of isolates tested: 542
Comments:
For historical susceptibility data click here
Numeric data represent local susceptibility data.
(+) = usually effective or >60% susceptible; (+/-) = clinical trials lacking or 30-60% susceptible; (-) = not effective clinically or <30% susceptible - Adapted with permission from The Sanford Guide to Antimicrobial Therapy
(*) Local (non-Sanford Guide) opinion
(S) = synergistic with penicillin/ampicillin;
(&) nitrofurantoin only useful for lower tract urinary tract infections
(+) = usually effective or >60% susceptible; (+/-) = clinical trials lacking or 30-60% susceptible; (-) = not effective clinically or <30% susceptible - Adapted with permission from The Sanford Guide to Antimicrobial Therapy
(*) Local (non-Sanford Guide) opinion
(S) = synergistic with penicillin/ampicillin;
(&) nitrofurantoin only useful for lower tract urinary tract infections